According to Anika Therapeutics's latest financial reports the company's current EPS (TTM) is -1,46ย โฌ. In 2022 the company made an earnings per share (EPS) of -0,98ย โฌ a decrease over its 2021 EPS that were of 0,28ย โฌ.